Topiramate Tablet, Film Coated
Product Images NDC 71335-1684

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-1684). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

39703b05 F774 4aed 9792 000a61531553 01

FDA Label Image

39703b05 F774 4aed 9792 000a61531553 02

39703b05 F774 4aed 9792 000a61531553 02
This is a graph showing the cumulative rates for time to the first seizure in two groups of participants who were given two different doses of Topiramate (50 mg/day and 400 mg/day) for treatment. The graph shows that the group taking 400 mg/day had a significantly lower rate of first seizure than the group taking 50 mg/day (p=0.0002). The graph also shows time in days along the X-axis and cumulative rates along the Y-axis.*
FDA Label Image

39703b05 F774 4aed 9792 000a61531553 03

39703b05 F774 4aed 9792 000a61531553 03
The text provides information on the change from baseline to double-blind phase in the average monthly migraine period rate for different doses of topiramate compared to a placebo. The results of the study are represented in a tabular form, including the number of participants at each dose level and the statistical significance. Therefore, the text describes the findings of a clinical trial on the efficacy of topiramate for the prevention of migraines.*
FDA Label Image

Label Image (Lbl713351684)

Label Image (Lbl713351684)
This seems to be a medication description of Topiramate 25mg Tab, which is a white round tablet with the imprint ZD;16. It is a generic version of Topamax 25mg Tab manufactured by Cadila Healthcare Limited. The medication should be stored at room temperature of 20°-25°C (68™-77°F) and kept tightly closed. The rest of the text seems to be identifying information such as batch number, expiration date, and NDC number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.